Neuroprotective Lithium Salts Protect Pancreatic β-Сells from Damage


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We studied antidiabetic effects and cytoprotective activity of two lithium salts (lithium chloride and lithium carbonate) on the model of streptozotocin-induced diabetes mellitus type 2 in Wistar rats. Using the method of β-cells detection with antibodies to insulin, we demonstrated that streptozotocin reduced the number of β-cells and impaired their morphological structure. Both lithium preparations administered to diabetic animals for 28 days in doses of 10 and 8.9 mg/kg, respectively, attenuated the damaging effect of streptozotocin. This cytoprotective effect of lithium salts manifested in weakening of hyperglycemia, polyphagia, polydipsia, and weight loss. A satisfactory correlation between the morphometric data and blood glucose levels was revealed. The mechanisms of the multitarget action of lithium salts are discussed.

Sobre autores

R. Ostrovskaya

Laboratory of Psychopharmacology, V. V. Zakusov Research Institute of Pharmacology

Autor responsável pela correspondência
Email: rita.ostrovskaya@gmail.com
Rússia, Moscow

S. Ivanov

Laboratory of Psychopharmacology, V. V. Zakusov Research Institute of Pharmacology

Email: rita.ostrovskaya@gmail.com
Rússia, Moscow

A. Durnev

Laboratory of Psychopharmacology, V. V. Zakusov Research Institute of Pharmacology

Email: rita.ostrovskaya@gmail.com
Rússia, Moscow


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies